Synthesis and Anticancer Activity Study of New Bis‐1,3‐Oxazole‐5‐Sulfonylamides
- 3 December 2025
- journal article
- Published by Wiley in ChemMedChem
- Vol. 21 (4) , e202500921
Abstract
In the present study, eight novel substituted 4‐cyano‐ N ‐(4‐cyano‐1,3‐oxazol‐5‐yl)‐ N ‐alkyl‐1,3‐oxazole‐5‐sulfonylamides have been synthesized. Compounds are characterized by IR, 1 H, 13 C NMR spectroscopy, elemental analysis, and chromato‐mass‐spectrometry. The anticancer activities of six compounds are evaluated against the NCI‐60 human tumor cell line panel. The tested compounds exhibit the strongest antiproliferative (TGI) and cytotoxic (LC 50 ) activities within the leukemia, non‐small‐cell lung cancer, melanoma, and colon cancer subpanels. Overall, the mean activity parameters (GI 50 , TGI, and LC 50 ) calculated for three compounds do not differ significantly and are within the range of 1–100 µM, and for some lines, it reaches the value 10 −8 mol L −1 . Structure–activity relationship analysis reveals markedly higher activity for bisoxazole derivatives bearing 4‐MeC 6 H 4 or 4‐FC 6 H 4 at the second position of the oxazole rings (compounds 2 , 3 , and 7 ), whereas derivatives with diphenyl, di‐tolyl substituents (compounds 1 and 6 ), or 4‐ClC 6 H 4 (compound 8 ) exhibit substantially lower anticancer activity. In addition, the potential molecular mechanisms of anticancer action of these compounds are investigated using molecular docking methods. Derivatives show the highest affinity for tubulin and cyclin‐dependent kinases. Docking of 4‐cyano‐ N ‐[4‐cyano‐2‐(4‐fluorophenyl)‐1,3‐oxazol‐5‐yl]‐ N ‐methyl‐2‐(4‐methylphenyl)‐1,3‐oxazole‐5‐sulfonamide into the colchicine‐binding site of αβ‐tubulin reveals a binding affinity of −10.9 kcal mol −1 , with the ligand located at the subunit interface.Keywords
Funding Information
- National Academy of Sciences of Ukraine (Novel synthetic nitrogen‐containing heterocyclic compounds with antimicrobial and anti‐cancer activity (Contract №29/02‐2024(5) from 19.02.2024)
This publication has 24 references indexed in Scilit:
- Sulfonamides as anticancer agents: A brief review on sulfonamide derivatives as inhibitors of various proteins overexpressed in cancerBioorganic Chemistry, 2024
- Synthesis, characterization of novel N‐(4‐cyano‐1,3‐oxazol‐5‐yl)sulfonamide derivatives and in vitro screening their activity against NCI‐60 cancer cell linesChemMedChem, 2024
- Comprehensive review on the Bis–heterocyclic compounds and their anticancer efficacyJournal of Molecular Structure, 2022
- Design, synthesis and evaluation of novel sulfonamides as potential anticancer agentsComputational Biology and Chemistry, 2018
- Synthesis, antitumor activity and CDK1 inhibiton of new thiazole nortopsentin analoguesEuropean Journal of Medicinal Chemistry, 2017
- Synthesis, biological evaluation and 3D-QSAR study of novel 4,5-dihydro-1H-pyrazole thiazole derivatives as BRAFV600E inhibitorsBioorganic & Medicinal Chemistry, 2015
- Class I HDACs Share a Common Mechanism of Regulation by Inositol PhosphatesMolecular Cell, 2013
- An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding SitePharmaceutical Research, 2012
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screenDrug Development Research, 1995